Ribavirin
Showing 26 - 50 of 1,209
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Hepatitis C, Chronic Trial in United States (ISIS 14803, peginterferon alfa, ribavirin)
Completed
- Hepatitis C, Chronic
- ISIS 14803, peginterferon alfa, ribavirin
-
Birmingham, Alabama
- +24 more
Dec 1, 2022
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
HIV, Hepatitis C Trial in United States (Ribavirin, Aldesleukin, Peginterferon alfa-2b)
Completed
- HIV Infections
- Hepatitis C
- Ribavirin
- +2 more
-
Los Angeles, California
- +7 more
Oct 28, 2021
Chronic Hepatitis Trial in Italy (Peginterferon alpha-2a + Ribavirin)
Completed
- Chronic Hepatitis
- Peginterferon alpha-2a + Ribavirin
-
Avellino, Italy
- +34 more
Mar 9, 2022
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)
Completed
- Chronic Hepatitis C Virus Infection
- P1101 + Ribavirin
- PEG-Intron + Ribavirin
-
Beijing, China
- +38 more
Jan 14, 2022
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
SARS-CoV2, COVID-19 Trial in Ankara, Istanbul (Ribavirin Capsules, Favipiravir)
Not yet recruiting
- SARS-CoV2
- COVID-19
- Ribavirin Capsules
- Favipiravir
-
Ankara, Cebeci, Turkey
- +3 more
Apr 1, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (non-cirrhotic subjects. low TG-2349+ low
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
- +5 more
-
Beijing, Beijing, ChinaPeking University Peoples Hospital
Feb 16, 2021
Hemorrhagic Fever With Renal Syndrome Trial in Seoul (Ribavirin)
Enrolling by invitation
- Hemorrhagic Fever With Renal Syndrome
- Ribavirin
-
Seoul, Korea, Republic ofBrian Allgood Army Community Hospital (121st Combat Support)
Feb 10, 2021
Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)
Completed
- Hepatitis C Infection
- HIV Infection
- Nitazoxanide With Pegylated Interferon And Ribavirin
-
Washington, District of Columbia
- +3 more
Sep 14, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
Jan 15, 2021
Multidisciplinary Support Program in Chronic Hepatitis C
Completed
- Hepatitis C, Chronic
- Multidisciplinary support program
-
Barcelona, SpainHospital del Mar
Sep 15, 2021
HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a
Completed
- HIV Infection
- Hepatitis C Infection
- Nitazoxanide (NTZ)
- +2 more
-
Birmingham, Alabama
- +17 more
Nov 2, 2021
Chronic Hepatitis C Trial in Cairo (Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir /
Recruiting
- Chronic Hepatitis C
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
-
Cairo, EgyptFaculty of medicine Helwan University
Jan 3, 2021
Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Hepatitis C, Hemodialysis, Nosocomial Infection Trial in Philadelphia (Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier])
Completed
- Hepatitis C
- +2 more
- Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier]
-
Philadelphia, PennsylvaniaPenn Presbyterian Medical Center
Nov 17, 2021